• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

修改 INSM1 启动子以保留其特异性和活性,用于神经内分泌癌的腺病毒基因治疗。

Modifications to the INSM1 promoter to preserve specificity and activity for use in adenoviral gene therapy of neuroendocrine carcinomas.

机构信息

Research Institute for Children, Children's Hospital, New Orleans, LA 70118, USA.

出版信息

Cancer Gene Ther. 2012 Dec;19(12):828-38. doi: 10.1038/cgt.2012.66. Epub 2012 Oct 19.

DOI:10.1038/cgt.2012.66
PMID:23079673
Abstract

The INSM1 gene encodes a transcriptional repressor that is exclusively expressed in neuronal and neuroendocrine tissue during embryonic development that is re-activated in neuroendocrine tumors. Using the 1.7 kbp INSM1 promoter, an adenoviral HSV thymidine kinase gene therapy was tested for the treatment of neuroendocrine tumors. An unforeseen interference on the INSM1 promoter specificity from the adenoviral genome was observed. Attempts were made to protect the INSM1 promoter from the influence of essential adenoviral sequences and to further enhance the tissue specificity of the INSM1 promoter region. Using the chicken β-globin HS4 insulator sequence, we eliminated off-target tissue expression from the Ad-INSM1 promoter-luciferase2 constructs in vivo. In addition, inclusion of two copies of the mouse nicotinic acetylcholine receptor (n(AchR)) neuronal-restrictive silencer element (NRSE) reduced nonspecific activation of the INSM1 promoter both in vitro and in vivo. Further, inclusion of both the HS4 insulator with the n(AchR) 2 × NRSE modification showed a two log increase in luciferase activity measured from the NCI-H1155 xenograft tumors compared with the original adenovirus construct. The alterations increase the therapeutic potential of adenoviral INSM1 promoter-driven suicide gene therapy for the treatment of a variety of neuroendocrine tumors.

摘要

INSM1 基因编码一种转录抑制剂,在胚胎发育过程中仅在神经元和神经内分泌组织中表达,在神经内分泌肿瘤中重新激活。使用 1.7 kbp INSM1 启动子,测试了腺病毒 HSV 胸苷激酶基因治疗神经内分泌肿瘤的效果。观察到腺病毒基因组对 INSM1 启动子特异性的意外干扰。试图保护 INSM1 启动子免受必需腺病毒序列的影响,并进一步增强 INSM1 启动子区域的组织特异性。使用鸡β-珠蛋白 HS4 绝缘子序列,我们消除了体内 Ad-INSM1 启动子-荧光素酶 2 构建体的非靶向组织表达。此外,包含两个拷贝的小鼠烟碱型乙酰胆碱受体(n(AchR))神经元限制性沉默元件(NRSE)可减少 INSM1 启动子在体外和体内的非特异性激活。此外,包含 HS4 绝缘子和 n(AchR)2×NRSE 修饰可使 NCI-H1155 异种移植肿瘤中测量的荧光素酶活性增加两个对数级,与原始腺病毒构建体相比。这些改变增加了腺病毒 INSM1 启动子驱动自杀基因治疗治疗各种神经内分泌肿瘤的治疗潜力。

相似文献

1
Modifications to the INSM1 promoter to preserve specificity and activity for use in adenoviral gene therapy of neuroendocrine carcinomas.修改 INSM1 启动子以保留其特异性和活性,用于神经内分泌癌的腺病毒基因治疗。
Cancer Gene Ther. 2012 Dec;19(12):828-38. doi: 10.1038/cgt.2012.66. Epub 2012 Oct 19.
2
Detection of neuroendocrine tumors using promoter-specific secreted Gaussia luciferase.利用启动子特异性分泌型海肾荧光素酶检测神经内分泌肿瘤。
Int J Oncol. 2016 Jan;48(1):173-80. doi: 10.3892/ijo.2015.3223. Epub 2015 Oct 30.
3
Tumor-specific promoter-driven adenoviral therapy for insulinoma.肿瘤特异性启动子驱动的腺病毒治疗胰岛素瘤。
Cell Oncol (Dordr). 2016 Jun;39(3):279-86. doi: 10.1007/s13402-016-0274-8. Epub 2016 Feb 22.
4
The insulinoma-associated 1: a novel promoter for targeted cancer gene therapy for small-cell lung cancer.胰岛素瘤相关蛋白1:一种用于小细胞肺癌靶向癌症基因治疗的新型启动子
Cancer Gene Ther. 2006 Apr;13(4):375-84. doi: 10.1038/sj.cgt.7700887.
5
Adenoviral insulinoma-associated protein 1 promoter-driven suicide gene therapy with enhanced selectivity for treatment of neuroendocrine cancers.腺病毒胰岛素瘤相关蛋白1启动子驱动的自杀基因疗法,对神经内分泌癌的治疗具有更高的选择性。
Ochsner J. 2013 Spring;13(1):91-9.
6
INSM1 promoter-driven adenoviral herpes simplex virus thymidine kinase cancer gene therapy for the treatment of primitive neuroectodermal tumors.INSM1 启动子驱动的腺相关病毒单纯疱疹病毒胸苷激酶癌症基因治疗用于治疗原始神经外胚层肿瘤。
Hum Gene Ther. 2009 Nov;20(11):1308-18. doi: 10.1089/hum.2008.168.
7
Single agent- and combination treatment with two targeted suicide gene therapy systems is effective in chemoresistant small cell lung cancer cells.单一制剂和两种靶向自杀基因治疗系统联合治疗对化疗耐药的小细胞肺癌细胞有效。
J Gene Med. 2012 Jul;14(7):445-58. doi: 10.1002/jgm.2630.
8
Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo.腺病毒介导的缺氧靶向基因治疗,使用单纯疱疹病毒胸苷激酶和细菌硝基还原酶前药激活基因,在体外和体内。
Cancer Gene Ther. 2011 Nov;18(11):773-84. doi: 10.1038/cgt.2011.43. Epub 2011 Aug 12.
9
Neuron-restrictive silencer elements mediate neuron specificity of adenoviral gene expression.神经元限制性沉默元件介导腺病毒基因表达的神经元特异性。
Nat Biotechnol. 1999 Sep;17(9):865-9. doi: 10.1038/12849.
10
The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.端粒酶逆转录酶启动子驱动有效的肿瘤自杀基因治疗,同时防止组成型启动子所导致的肝毒性。
Gene Ther. 2001 Apr;8(7):568-78. doi: 10.1038/sj.gt.3301421.

引用本文的文献

1
Structural insights into a highly flexible zinc finger module unravel INSM1 function in transcription regulation.对高度灵活的锌指模块的结构洞察揭示了INSM1在转录调控中的功能。
Nat Commun. 2025 Mar 4;16(1):2162. doi: 10.1038/s41467-025-57478-2.
2
Insulinoma-Associated-1: From Neuroendocrine Tumor Marker to Cancer Therapeutics.胰岛素瘤相关蛋白 1:从神经内分泌肿瘤标志物到癌症治疗策略。
Mol Cancer Res. 2019 Aug;17(8):1597-1604. doi: 10.1158/1541-7786.MCR-19-0286. Epub 2019 May 21.
3
Tumor-specific promoter-driven adenoviral therapy for insulinoma.
肿瘤特异性启动子驱动的腺病毒治疗胰岛素瘤。
Cell Oncol (Dordr). 2016 Jun;39(3):279-86. doi: 10.1007/s13402-016-0274-8. Epub 2016 Feb 22.
4
Adenoviral insulinoma-associated protein 1 promoter-driven suicide gene therapy with enhanced selectivity for treatment of neuroendocrine cancers.腺病毒胰岛素瘤相关蛋白1启动子驱动的自杀基因疗法,对神经内分泌癌的治疗具有更高的选择性。
Ochsner J. 2013 Spring;13(1):91-9.